Labcorp Holdings Inc.
Key Metrics
- Previous Close
- $368.24
- 52-Week Range
- $245.00 – $375.10
- Market Cap
- $30.11B
- P/E (TTM)
- 30.39
- EPS (TTM)
- 12.20
- Dividend Yield
- 0.78%
Advanced Metrics
- Price/Book
- 3.40
- PEG Ratio
- 1.64
- Return on Equity
- 11.44%
- Return on Assets
- 5.48%
- Gross Margin
- 28.96%
- Operating Margin
- 11.18%
- Profit Margin
- 6.88%
- Current Ratio
- 1.41
- Debt/Equity
- 0.77
- Total Debt
- $6.85B
- Free Cash Flow
- $1.06B
- Revenue Growth
- 6.90%
- Earnings Growth
- 3.20%
- Enterprise Value
- $36.71B
Market Snapshot
About
Labcorp Holdings Inc. is one of the world's leading global life sciences companies, providing comprehensive clinical laboratory and end-to-end drug development services. The company operates through two segments: Diagnostics Laboratories, offering routine and specialty testing services to healthcare providers and patients, and Biopharma Laboratory Services, supporting pharmaceutical companies in drug development from early research through post-market monitoring. Labcorp serves millions of patients and healthcare providers across more than 100 countries with a network of laboratories and patient service centers.